Viral Vector Production Market Value to Reach US$ 19.0 Bn by 2032: TMR Study

• Rise in demand for adeno-associated virus vector types is driving the viral vector production market
• Increase in demand for downstream processing workflow is propelling the market

WILMINGTON, Del., Dec. 14, 2022 /PRNewswire/ -- According to a study by Transparency Market Research, the global viral vector production market is expected to grow at a compound annual growth rate of 28.3% between 2022 and 2032.

The number of people suffering from different types of cancer has increased in the past few years. This has led to a rise in funding for research on cancer medications based on viral vectors and clinical testing of these products. Other application areas of viral vectors include cell & gene therapy development, vaccine development, biopharmaceutical & pharmaceutical discovery, and biomedical research.

Prominent players are launching new products to gain a competitive edge over other players and to generate new revenue streams. Leading players in the viral vector production market are adopting growth strategies such as collaboration with smaller players in order to expand their market presence and increase their revenue.

Get Exclusive PDF Sample Copy of Viral Vector Production Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85250 

Key Findings of Viral Vector Production Market Study

• Increase in Demand for Adeno-associated virus (AAV) Vectors Augmenting Market Growth: Based on vector type, the global market can be classified into adeno-associated virus (AAV), lentivirus, adenovirus, and retrovirus. Adeno-associated virus emerged as a leading segment in 2021. Adeno-associated virus vector does not contain large number of pathogens and has been extensively used as a vaccine due to its ability to generate strong cellular and humoral responses. Additionally, adeno-associated virus vector has been deployed as a CRISPR/Cas9 delivery method, which has led to successful genetic testing in the host DNA of several human cells. These factors contributed to the growth of the segment.
• Rise in Demand for Downstream Processing Fueling Market Development: Based on workflow type, the global viral vector production market can be bifurcated into upstream processing and downstream processing. Downstream processing emerged as the dominant segment in 2021. Increase in investment in the development of new technologies that would enable improved vector production and introduction of technologically advanced chromatography products are the major drivers of the segment.

Viral Vector Production Market - Key Drivers

• Increase in demand for viral vector-based vaccinations to treat patients suffering from different infectious diseases is driving the viral vector production market
• Rise in the number of government initiatives and measures, such as funding research & development activities undertaken by leading players, is likely to fuel viral vector production industry growth during the forecast period

Viral Vector Production Market - Regional Insights

• Asia Pacific is projected to emerge as the dominant region during the forecast period owing to increase in the number of approvals for new regenerative products and surge in investment in the healthcare industry in countries such as China and India
• The market in North America is expected to witness significant growth during the forecast period. This is ascribed to large presence of institutions in countries, such as the U.S., that focus on research & development of advanced therapies.

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=85250

Viral Vector Production Market - Key Players

The global viral vector production market is competitive and comprises large number of international and regional players. Entry of new players during the forecast period is likely to intensify the competition in the market.

Key players in the market are Thermo Fisher Scientific, Waisman Biomanufacturing, Merck KGaA, GE Healthcare, BioScience Laboratories, and CEVEC Pharmaceuticals GmbH.

The global viral vector production market is segmented as follows:

By Workflow Type

• Upstream Processing
• Vector Amplification & Expansion
• Vector Recovery & Harvesting
• Downstream Processing
• Purification
• Fill Finish

By Vector Type

• Adeno-associated virus (AAV)
• Lentivirus
• Adenovirus
• Retrovirus
• Other vector types

By Application

• Cell & Gene Therapy Development
• Vaccine Development
• Biopharmaceutical and Pharmaceutical Discovery
• Biomedical Research

By End-use

• Pharmaceutical and Biopharmaceutical Companies
• Research Institutes

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Save up to 20% by purchasing this Premium Research Report | Immediate Delivery Available –https://www.transparencymarketresearch.com/checkout.php?rep_id=85250&ltype=S 

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

AI in Endoscopy Market: AI in Endoscopy Market is projected to advance at a CAGR of 26.9% between 2022 and 2031 to reach more than US$ 421.8 Mn by the end of 2031.

Endodontic Files Market: Endodontic files market is projected to advance at a CAGR of 6.1% between 2022 and 2032 to reach more than US$ 40.7 Mn by the end of 2032.

Pneumatic Tourniquet Market: Pneumatic tourniquet market is likely to reach a valuation of nearly US$ 1 Bn by the end of 2032 and to expand at a CAGR of 8% from 2022 to 2032.

Veterinary Antimicrobial Susceptibility Testing Market: Veterinary antimicrobial susceptibility testing market is expected to be worth nearly $76.2 billion by the end of 2032, with a CAGR of nearly 7% from 2022 to 2032.

Viral Vector Production Market: Viral vector creation market is worth more than US$ 1.3 Bn by 2032 and it is estimated to expand at a CAGR of 28.3% from 2022 to 2032.

Operating Room Integration Market: Operating room integration market is expected to exceed US$ 7.2 billion by the end of 2031, growing at a CAGR of 13.9% from 2022 to 2032.

Near Infrared Imaging Market: Near Infrared Imaging Market is anticipated to reach more than US$ 785.1 Mn by the end of 2032 and to grow at a CAGR of 12.7% from 2022 to 2032.

In-vitro Toxicology Testing Market: In Vitro Toxicology Testing Market is anticipated to reach more than US$ 91.3 Bn by the end of 2031 and to grow at a CAGR of 13% from 2022 to 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg